Primary Job Title Chairman Primary Organization 
Juventas Therapeutics
Gender Male
George Emont (Chairman) is a Managing Partner with Triathlon Medical Ventures and also a Managing Partner of the Kentucky Seed Capital Fund.
Mr. Emont's more than two decades of health care industry experience include 13 years in venture capital. Prior to joining Triathlon and KCSF, Mr. Emont was the Director of Venture Capital for Humana
Inc. where he managed a venture capital fund that made investments totaling over $75 million in 11 portfolio companies and three venture funds.
Mr. Emont's resume includes service with Baxter Healthcare Corporation and IAI Venture Capital Group, followed by the successful launch and eventual sale of oncology-focused biotechnology start-up OncoTherapeutics.
Mr. Emont currently represents Triathlon on the boards of Celleration, Pradama and Juventas.
For the Kentucky Seed Capital Fund he is on the boards of ApoImmune, RhinoCyte, AllTranz, and OrthoData.
Mr. Emont holds a B.A. from Oberlin College in Oberlin, Ohio, and an M.B.A. from the University of Chicago.
